1. Drug-induced peripheral neuropathy;Vilholm;Basic Clin Pharmacol Toxicol,2014
2. Rhabdomyolysis during therapy with daptomycin;Papadopoulos;Clin Infect Dis,2006
3. European Medicines Agency Cubicin (daptomicina). Annex I: Summary of product characteristics 2011 http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/000637/WC500036049.pdf
4. FDA label information Cubicin (daptomycin). Full prescribing information. 2011 https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021572s038lbl.pdf
5. Sunovion Pharmaceuticals Canada Cubicin (daptomycin). Part I: Health professional information. 2016 http://www.sunovion.ca/monographs/cubicin.pdf